U.S. Orthopedic Endoscopy Market (2026 - 2033)

U.S. Orthopedic Endoscopy Market Summary

The U.S. orthopedic endoscopy market size was valued at USD 223.7 million in 2025 and is projected to reach USD 232.0 million in 2026 to USD 299.9 million by 2033, at a CAGR of 3.7% from 2026 to 2033. The market growth is driven by the increasing volume of arthroscopic procedures and the growing adoption of outpatient and office-based orthopedic care. In addition, technological advancements in high-definition and small-diameter visualization systems, along with the rising adoption of disposable and needle arthroscopes, are expanding the application of orthopedic endoscopy.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Market Dynamics

The U.S. orthopedic endoscopy market is driven by the rising prevalence of musculoskeletal disorders, increasing sports-related injuries, and growing adoption of minimally invasive arthroscopic procedures. Technological advancements in high-definition imaging and surgical visualization systems, along with increasing preference for outpatient orthopedic surgeries and shorter recovery times, are supporting market growth.

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The X-axis represents the level of market concentration, ranging from low to high. The Y-axis represents various market characteristics, including industry competition, degree of innovation, level of mergers & acquisition activities, regulatory impact, product substitutes, and regional expansion.

The market is characterized by a high degree of innovation, as participants compete to differentiate through dedicated endoscopes, advanced imaging, and integrated visualization. For instance, in May 2025, Arthrex received FDA 510(k) clearance for its Arthrex Spine Endoscope, classified as an arthroscope under product code HRX, extending its endoscopic offering beyond its sports medicine heritage.

M&A activity is moderate, with leaders favoring targeted acquisitions and distribution partnerships over large mergers. For instance, in January 2026, Smith+Nephew completed its acquisition of Integrity Orthopedics, developer of the Tendon Seam rotator cuff repair system, for an initial USD 225 million plus up to USD225 million in performance-based payments.

To learn more about this report, Download Free Sample Report

Regulations significantly influence the market, as arthroscopes are Class II medical devices subject to FDA 510(k) clearance, with applicable reprocessing validation requirements for reusable devices. In September 2026, Stryker received FDA De Novo authorization for SportSuite Vision, a surgical application designed for use with Apple Vision Pro during specified hip arthroscopy procedures. This development highlights the expansion of regulatory pathways for digital surgical visualization technologies and encourage innovation in integrated imaging solutions.

The threat of substitutes is moderate, with competition arising from smaller-bore arthroscopes and alternative visualization systems. These technologies offer options for selected procedures that may reduce the need for conventional arthroscopy setups. In January 2025, Arthrex’s NanoScope System received FDA 510(k) clearance, providing a lower-profile visualization option for selected orthopedic procedures.

Regional expansion is moderate, with participants extending reach into ambulatory surgery centers and multispecialty operating rooms through partnerships. For instance, in February 2026, KARL STORZ and Smith+Nephew announced a strategic relationship to align Smith+Nephew's sports medicine portfolio with KARL STORZ's visualization, video management, and OR integration technologies for hospital ORs and ASCs.

Analyst Perspective

The U.S. orthopedic endoscopy market is driven by increasing adoption of minimally invasive arthroscopy and spinal procedures. Rising demand for tissue-sparing techniques and shorter recovery times supports market growth. Conventional arthroscopes remain widely used across joint procedures, while needle and small-diameter scopes are gaining traction in specialized applications. Product selection depends on image quality, scope diameter, maneuverability, and instrument compatibility. Hospitals remain key demand centers due to established surgical infrastructure and specialized expertise. Growing adoption of outpatient orthopedic procedures is supporting demand across ambulatory surgery centers, driven by procedural efficiency and healthcare cost considerations.

Product Type Insights

The arthroscopes segment accounted for the largest share of 95.9% in 2025, supported by its established use across a broad range of orthopedic procedures, including knee, shoulder, hip, ankle, and wrist arthroscopy. Arthroscopes provide direct visualization of joint space and are available in multiple configurations suited to different anatomical sites and procedural requirements. For instance, in August 2026, KARL STORZ received FDA 510(k) clearance for its HOPKINS Telescopes for Arthroscopy, supporting the continued availability of dedicated arthroscopic visualization systems for orthopedic applications.

The needle / small-diameter arthroscopes segment is expected to register the fastest CAGR during the forecast period, supported by their suitability for procedures involving smaller joints and anatomically constrained spaces. Their compact diameter enables access through smaller portals and supports visualization where conventional arthroscopes may have limited maneuverability. For instance, in September 2025, Arthrex announced the launch of its NanoNeedle Scope 2.0 following its first clinical use in a pediatric orthopedic case. This supports the use of small-diameter arthroscopes in pediatric and anatomically constrained orthopedic procedures.

Setting Insight

The hospital segment accounted for the largest share of 59.8% in 2025, supported by surgical infrastructure, advanced visualization capabilities, and access to multidisciplinary orthopedic care. Hospitals accommodate a broad range of arthroscopic procedures, including complex interventions requiring specialized equipment and postoperative monitoring. The availability of established operating room infrastructure and trained surgical teams supports continued use of arthroscopes across hospital-based orthopedic procedures. For instance, in June 2025, Northside Hospital reported the first ultra-minimally invasive endoscopic orthopedic surgery at its Gwinnett facility using Arthrex technology. The procedure reflects the use of advanced endoscopic visualization within hospital-based orthopedic services and supports demand for arthroscopic systems and associated instruments.

To learn more about this report, Download Free Sample Report

The ambulatory surgery centers (ASCs) segment is expected to register the fastest CAGR during the forecast period from 2026 to 2033, owing to the growing use of outpatient orthopedic procedures, shorter recovery requirements, and established same-day surgical pathways. ASCs provide dedicated surgical infrastructure for procedures that do not require prolonged hospitalization, supporting efficient utilization of arthroscopic systems. For instance, a study published in November 2025 analyzed 3,097 endoscopic orthopedic surgery procedures performed in U.S. ASCs and reported an increase in procedure volume, with notable activity in the Western U.S. The findings indicate continued adoption of ASCs for endoscopic orthopedic procedures and support demand for compact, procedure-specific arthroscopic visualization systems suited to outpatient surgical workflows.

Region Insights

The Southeast accounted for the largest share of 29.07% in 2025, supported by a broad orthopedic care network, established surgical infrastructure, and increasing availability of endoscopic procedures across the region. For instance, in May 2025, SGMC Health in Valdosta, Georgia, performed its first endoscopic spine surgery in partnership with Arthrex, adding endoscopic surgical capability to its orthopedic and spine services. The introduction of the procedure reflects the continued adoption of endoscopic techniques within orthopedic care in the Southeast and supports regional demand for endoscopic visualization systems.

The West is expected to register the fastest CAGR during the forecast period from 2026 to 2033. This is supported by the adoption of advanced endoscopic techniques across orthopedic and spine care and the availability of specialized surgical expertise. For instance, in March 2025, Hoag Orthopedic Institute in Irvine, California, performed the first single-portal endoscopic spine surgery in Orange County using Arthrex technology. The procedure used a single incision and was introduced as an ultra-minimally invasive approach for spinal conditions. The introduction of single-portal endoscopic surgery at a major orthopedic institute in Southern California reflects the adoption of advanced endoscopic techniques in the Western U.S. and supports demand for dedicated endoscopic visualization systems.

Key U.S. Orthopedic Endoscopy Company Insights:

Key companies in the U.S. orthopedic endoscopy market are pursuing business growth strategies, including product portfolio expansion, new product development, regulatory clearances, partnerships and collaborations, and acquisitions. These efforts are aimed at strengthening endoscopic visualization capabilities, expanding clinical applications, and increasing market presence.

Key U.S. Orthopedic Endoscopy Companies

• Arthrex

• Stryker.

• Smith+Nephew

• CONMED Corporation

• KARL STORZ

• Zimmer Biomet

• Richard Wolf GmbH

• Olympus Corporation

• Integrated Endoscopy

• SCHÖLLY FIBEROPTIC GMBH

Recent Developments:

• In July 2026, Smith+Nephew's TESSA Spatial Surgery System received FDA De Novo classification, bringing AI-powered personalized planning, augmented reality, advanced imaging, navigation and real-time tracking to arthroscopic procedures. The system overlays patient-specific 3D anatomical models onto live 4K arthroscopic video and is initially indicated to assist femoral tunnel placement during ACL reconstruction.

“The TESSA System is modernizing ACL surgery by solving an unmet need,” said Dr. Anil Ranawat, Chief of the Hip and Knee Division of Sports Medicine at Hospital for Special Surgery in New York.

• In February 2026, KARL STORZ and Smith+Nephew announced a strategic relationship combining Smith+Nephew’s Sports Medicine portfolio with KARL STORZ’s visualization, video-management and OR-integration technologies for hospitals and ASCs.

“We’re excited to collaborate with Smith+Nephew to support orthopedic and multispecialty surgical teams,” said Fernando Morales, Vice President of Sales and Marketing, Surgical and OR1

• In January 2026, Smith+Nephew completed its acquisition of U.S.-based Integrity Orthopaedics, strengthening its Sports Medicine shoulder-repair portfolio with the Tendon Seam rotator-cuff repair system.

• In July 2025, Integrated Endoscopy’s assets were offered through a secured-party sale under UCC Article 9, with an auction announced for August 2025. The transaction involved the company’s endoscopy-related assets and represented a change in the ownership and commercialization status of its technology portfolio.

• In July 2025, Arthrex received FDA clearance expanding the NanoScope Operative Arthroscopy System for use in pediatric orthopedic procedures and laparoscopy, broadening the U.S. indications for its minimally invasive visualization platform.

• In April 2025, Zimmer Biomet completed its acquisition of Paragon 28, expanding its orthopedic portfolio in foot and ankle surgery.

U.S. Orthopedic Endoscopy Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global U.S. orthopedic endoscopy market report based on product type, setting, and region.

• Product Type Outlook (Revenue, USD Million, 2021 - 2033), (Unit Volume, 000’ Units, 2021-2033), (Install Base, 000’ Units, 2021-2033), (ASP, Units, 2021-2033)

  • Arthroscopes

    • Disposable Arthroscopes

      • Knee Arthroscopy

      • Shoulder Arthroscopy

      • Hip Arthroscopy

      • Small Joint Arthroscopy

        • Ankle / Foot

        • Elbow

        • Wrist / Hand

        • Other Small Joints

    • Reusable Arthroscopes

      • Knee Arthroscopy

      • Shoulder Arthroscopy

      • Hip Arthroscopy

      • Small Joint Arthroscopy

        • Ankle / Foot

        • Elbow

        • Wrist / Hand

        • Other Small Joints

  • Needle / Small-Diameter Arthroscopes

    • Disposable Needle Arthroscopes

      • Knee

      • Shoulder

      • Ankle / Foot

      • Wrist / Hand

      • Elbow

      • Other Small Joints

    • Reusable Needle / Small-Diameter Arthroscopes

      • Knee

      • Shoulder

      • Ankle / Foot

      • Elbow

      • Wrist / Hand

      • Other Small Joints

• Setting Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospital

    • Inpatient

    • Outpatient

  • Ambulatory Surgery Centers (ASCs)

  • Physician Office / Office-Based

• Region Outlook (Revenue, USD Million, 2021 - 2033), (Unit Volume, 000’ Units, 2021-2033), (Install Base, 000’ Units, 2021-2033), (ASP, Units, 2021-2033)

  • Northeast

  • Southeast

  • Midwest

  • Southwest

  • West

Research Methodology

The U.S. orthopedic endoscopy market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each U.S. Orthopedic endoscopy segment quantified using the revenue-capture definitions in the table below.

Estimation Model

To learn more about this report, Download Free Sample Report

Market-specific Research Models:

The U.S. orthopedic endoscopy market was estimated using supply-side and demand-side models. Public data, product evidence, existing primary research, and internal databases were used to validate the key assumptions.

The model covers 2021 to 2033. Values for 2021 to 2024 are modeled historical estimates, 2025 is the base year, and 2026 to 2033 are forecasts. All annual estimates were built from the underlying drivers rather than applying one common growth rate to every segment.

• Model 1: Commodity Flow Analysis - For publicly listed companies, annual reports, 10-K filings, investor presentations, earnings releases, and geographical revenue disclosures were reviewed. For private companies and subsidiaries, revenue information was sourced from company disclosures and premium paid databases, including S&P Global, Crunchbase, ZoomInfo, and RocketReach. Orthopedic endoscope revenue was derived using product portfolio, U.S. availability, FDA clearance, site-of-care suitability, market penetration, and product-level ASP.

• Model 2: Demand-based Market Sizing Framework

• Model 3: Primary Market Research Validation

• Model 4: Internal Database

• Model 5: U.S. orthopedic Endoscopy Market CAGR Calculations

Market Scope and Product Boundary

In scope: Reusable and single-use standard arthroscopes, as well as reusable and single-use needle/small-diameter arthroscopes used for joint visualization during knee, shoulder, hip, ankle/foot, elbow, wrist/hand, and other small-joint arthroscopic procedures.

Out of scope: Shavers, RF ablation devices, irrigation and fluid-management systems, cannulas and access portals, suture anchors and other fixation devices, cameras and camera heads, processors, monitors, light sources, OR towers, service contracts, and reusable handle assemblies sold separately from the optical scope. General-purpose endoscopes that are not specifically cleared or marketed for joint visualization are also excluded, even when used in arthroscopic procedures.

Model 1: Commodity Flow Analysis

Commodity flow analysis is the principal supply-side methodology used to derive and validate the U.S. Orthopedic Endoscopy market size. The approach reconstructs the market revenue pool from company-level financial information and product-level revenue estimates.

For publicly listed companies, financial data was sourced from annual reports, 10-K filings, investor presentations, earnings releases, and official geographical disclosures. Where companies did not report Orthopedic endoscopy revenue separately, the analysis started with the reported business segment and applied a transparent revenue-allocation framework.

For private companies and subsidiaries, the latest available revenue information was sourced from official company disclosures and premium databases, including S&P Global, Crunchbase, ZoomInfo, and RocketReach. The U.S. orthopedic endoscopy contribution was estimated using product breadth, U.S. commercial presence, regulatory availability, distribution coverage, installed-base potential, replacement demand, and product ASP.

Model 1: Commodity Flow Analysis

To learn more about this report, Download Free Sample Report

Commodity flow analysis was employed to track the movement of U.S. Orthopedic endoscopy through the value chain, from technology providers to end users. This analysis provided insights into demand generation points, intermediary roles, and ultimate consumption patterns.